Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What therapies are on the horizon for HER2 positive breast cancer?
Viale G, Morganti S, Ferraro E, Zagami P, Marra A, Curigliano G. Viale G, et al. Among authors: zagami p. Expert Rev Anticancer Ther. 2019 Sep;19(9):811-822. doi: 10.1080/14737140.2019.1660164. Epub 2019 Aug 28. Expert Rev Anticancer Ther. 2019. PMID: 31448640 Review.
Management of Cardiac Toxicity Induced by Chemotherapy.
Trapani D, Zagami P, Nicolò E, Pravettoni G, Curigliano G. Trapani D, et al. Among authors: zagami p. J Clin Med. 2020 Sep 7;9(9):2885. doi: 10.3390/jcm9092885. J Clin Med. 2020. PMID: 32906611 Free PMC article. Review.
Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature.
Conforti F, Tarantino P, Trillo P, Pala L, Zagami P, Pirola S, Di Venosa B, Catania C, Queirolo P, Pennacchioli E, Della Vigna P, Curigliano G, De Pas TM. Conforti F, et al. Among authors: zagami p. Cancer Treat Rev. 2021 Jan;92:102133. doi: 10.1016/j.ctrv.2020.102133. Epub 2020 Dec 3. Cancer Treat Rev. 2021. PMID: 33296826
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials.
Conforti F, Pala L, Bagnardi V, Specchia C, Oriecuia C, Marra A, Zagami P, Morganti S, Tarantino P, Catania C, De Marinis F, Queirolo P, De Pas T. Conforti F, et al. Among authors: zagami p. JNCI Cancer Spectr. 2020 Jul 29;4(6):pkaa064. doi: 10.1093/jncics/pkaa064. eCollection 2020 Dec. JNCI Cancer Spectr. 2020. PMID: 33344882 Free PMC article. Review.
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.
Esposito A, Marra A, Bagnardi V, Frassoni S, Morganti S, Viale G, Zagami P, Varano GM, Buccimazza G, Orsi F, Venetis K, Mazzarella L, Viale G, Fusco N, Criscitiello C, Curigliano G. Esposito A, et al. Among authors: zagami p. Eur J Cancer. 2021 Mar;145:197-209. doi: 10.1016/j.ejca.2020.12.028. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33493979
First line treatment of BRAF mutated advanced melanoma: Does one size fit all?
Giugliano F, Crimini E, Tarantino P, Zagami P, Uliano J, Corti C, Trapani D, Curigliano G, Ascierto PA. Giugliano F, et al. Among authors: zagami p. Cancer Treat Rev. 2021 Sep;99:102253. doi: 10.1016/j.ctrv.2021.102253. Epub 2021 Jun 18. Cancer Treat Rev. 2021. PMID: 34186441 Review.
58 results